home / stock / irix / irix news


IRIX News and Press, IRIDEX Corporation From 11/11/25

Stock Information

Company Name: IRIDEX Corporation
Stock Symbol: IRIX
Market: NASDAQ
Website: iridex.com

Menu

IRIX IRIX Quote IRIX Short IRIX News IRIX Articles IRIX Message Board
Get IRIX Alerts

News, Short Squeeze, Breakout and More Instantly...

IRIX - IRIDEX GAAP EPS of -$0.09, revenue of $12.5M

2025-11-11 16:10:35 ET More on IRIDEX Iridex regains Nasdaq listing compliance Seeking Alpha’s Quant Rating on IRIDEX Financial information for IRIDEX Read the full article on Seeking Alpha For further details see: IRIDEX GAAP EPS of -$0.09...

IRIX - Iridex Reports Third Quarter 2025 Financial Results

MOUNTAIN VIEW, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial result...

IRIX - IRIX - Historical Price Movements Surrounding Earnings

2025-11-10 17:42:14 ET IRIDEX Corporation (IRIX) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 6.82%. The average open to low on the day of earnings was -6.76%. The average open to clo...

IRIX - IRIX - Historical Earnings Price Analysis

2025-11-10 17:37:14 ET IRIDEX Corporation (IRIX) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in IRIX stock price following earnings has averaged ±7.07% , with a median of 5.77%. T...

IRIX - Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025

MOUNTAIN VIEW, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced plans to releas...

IRIX - Iridex regains Nasdaq listing compliance

2025-09-09 16:42:32 ET More on IRIDEX IRIDEX Corporation (IRIX) Q2 2025 Earnings Call Transcript Iridex outlines further cost reductions and targets profitability in 2025 as Q2 revenue rises 14% sequentially Financial information for IRIDEX Read the full ar...

IRIX - Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance

MOUNTAIN VIEW, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced that it h...

IRIX - Iridex outlines further cost reductions and targets profitability in 2025 as Q2 revenue rises 14% sequentially

2025-08-12 21:10:31 ET More on IRIDEX IRIDEX Corporation (IRIX) Q2 2025 Earnings Call Transcript Financial information for IRIDEX Read the full article on Seeking Alpha For further details see: Iridex outlines further cost reductions and targets profitabi...

IRIX - IRIDEX Corporation (IRIX) Q2 2025 Earnings Call Transcript

2025-08-12 21:09:47 ET IRIDEX Corporation (IRIX) Q2 2025 Earnings Conference Call August 12, 2025 05:00 PM ET Company Participants Patrick Mercer - CEO, President & Director Romeo R. Dizon - Chief Financial Officer Conference Call Participants Philip ...

IRIX - IRIDEX GAAP EPS of -$0.06, revenue of $13.6M

2025-08-12 16:14:28 ET More on IRIDEX Financial information for IRIDEX Read the full article on Seeking Alpha For further details see: IRIDEX GAAP EPS of -$0.06, revenue of $13.6M

Previous 10 Next 10